VIP for Gut: Evidence-Graded Look at Vasoactive Intestinal Peptide
What's breaking down
The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.
Why VIP might help you
- Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.
How these fit together
Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.
- VIP → immune / autonomic
What the evidence actually shows
This is a count of what is in this ledger — not a claim about all research worldwide.
- Scientific sources catalogued (PubMed, trials, reviews): 4
- Claims tagged human evidence: 1
- Claims tagged preclinical (animal/lab): 2
- Claims tagged anecdotal: 1
- Reddit posts catalogued: 1
- X posts catalogued: 0
- Other anecdote sources (YouTube, Instagram, etc.): 0
- Total sources in chain: 5
Quantified confidence (this ledger): 0.32 / 1.00 — low — animal and anecdote heavy
Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.
What scientists say
Recent advances in vasoactive intestinal peptide physiology... (source s1)
Observational human IBD VIP level changes noted.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Therapeutic effects of vasoactive intestinal peptide in the TNBS model... (source s2)
Rat colitis model protection by VIP.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Vasoactive Intestinal Peptide Deficiency Is Associated With... (source s3)
VIP KO mouse microbiota and barrier findings.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Research advances of vasoactive intestinal peptide in... (source s5)
Mechanistic barrier and immune effects.
Evidence type: Published research.
What people say on Reddit
VIP (Vasoactive Intestinal Peptide): The Overlooked... — Reddit, r/PeptideFeed (source s4)
User discussion on gut tolerance.
---
Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.
Evidence ledger 5 · tier-ranked · API
Ask this article · 8 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.